Mathieu Anheim

16.5k citations
246 papers · 12.4k · 7 hit papers · h-index 53

Impact in

  • Neurology top 0.1%
    • Parkinson's Disease Mechanisms and Treatments
    • Long-Term Effects of COVID-19
    • Neurological disorders and treatments
    • Genetic Neurodegenerative Diseases
    • Hereditary Neurological Disorders

Papers in

    • Genetic Neurodegenerative Diseases 87
    • Hereditary Neurological Disorders 35
    • Parkinson's Disease Mechanisms and Treatments 52
    • Neurological disorders and treatments 37
    • Neurological diseases and metabolism 15

Mathieu Anheim

236 papers receiving 12.1k citations

Mathieu Anheim's Hit Papers

PFMG2025–integrating genomic medicine into the national healthcare system in France 2025 · 26 citations
260+4+8Years since publication5001k1.5k2k

Peers

Mathieu Anheim
Comparison fields: 5 of 139
  • Neurology 4.9k
  • Cellular and Molecular Neuroscience 3.3k
  • Neurology 724
  • Clinical Biochemistry 214
  • Infectious Diseases 744
Replace Tanya Stojkovic with:
Tanya Stojkovic France
Rita J. Balice‐Gordon United States
Thomas O. Crawford United States
Michael D. Geschwind United States
Pierre M. Labauge France
Christine Tranchant France
Carol Kaiser Petito United States
Josep O. Dalmau United States
E. Tessa Hedley‐Whyte United States
Lucio Santoro Italy
Mathieu Anheim relative to Tanya Stojkovic France Tanya Stojkovic's profile →
Citations per field
00.5×2×4×6×8×
Tanya Stojkovic · 1×
Citations per year

Countries citing papers authored by Mathieu Anheim

Since Specialization
Citations

This map shows the geographic impact of Mathieu Anheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Anheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Anheim more than expected).

Fields of papers citing papers by Mathieu Anheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Anheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Anheim. The network helps show where Mathieu Anheim may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathieu Anheim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathieu Anheim Line = papers co-authored together Mathieu Anheim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neurologic Features in Severe SARS-CoV-2 Infection
Hit paper breakdown →
20202058
2
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Hit paper breakdown →
2013576
3
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
Hit paper breakdown →
2016355
4
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study
Hit paper breakdown →
2020350
5 2012278
6
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
Hit paper breakdown →
2020269
7 2008267
8
Trial of Lixisenatide in Early Parkinson’s Disease
Hit paper breakdown →
2024244
9 2017242
10 2010239
11 2012211
12 2009202
13 2007200
14 2017186
15 2013185
16 2020166
17 2010147
18 2012143
19 2009140
20 2012135

About Mathieu Anheim

Mathieu Anheim is a scholar working on Cellular and Molecular Neuroscience, Neurology, Neurology, Genetics and Endocrinology, Diabetes and Metabolism, having authored 246 papers that have together received 12.4k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (87 papers), Parkinson's Disease Mechanisms and Treatments (52 papers), Neurological disorders and treatments (37 papers), Hereditary Neurological Disorders (35 papers), Neurological diseases and metabolism (15 papers), Genomics and Rare Diseases (14 papers), Neurological and metabolic disorders (13 papers) and Genetics and Neurodevelopmental Disorders (12 papers). The work is most often cited by research in Neurology (4.9k citations), Cellular and Molecular Neuroscience (3.3k citations), Neurology (724 citations), Clinical Biochemistry (214 citations) and Infectious Diseases (744 citations). Mathieu Anheim has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Christine Tranchant, Clotilde Boulay, Stéphane Kremer, Julie Helms, Mickaël Ohana, Hamid Merdji, Ferhat Meziani, M. Schenck, Raphaël Clère-Jehl and Christine Kummerlen. Their work appears in journals such as Journal of Neurology, Movement Disorders, Brain, Neurology and Parkinsonism & Related Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact